N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine

C135H165N51O4S5 — CID 159635423

About N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine

N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine (PubChem CID 159635423) has the molecular formula C135H165N51O4S5 and a molecular weight of 2726.49 g/mol. Its IUPAC name is N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine.

Molecular Properties

• Compound Name: N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine
• PubChem CID: 159635423
• Molecular Formula: C135H165N51O4S5
• Molecular Weight: 2726.49 g/mol
• Exact Mass: 2724.29
• IUPAC Name: N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine
• SMILES: C1=CN=C(CNCC2=NC=CC2)C1.CC(=O)N(Cc1ccccn1)Cc1ccccn1.Cc1cc(C)n(CN(C)Cn2nc(C)cc2C)n1.Cc1cc(C)n(CNCn2nc(C)cc2C)n1.Cn1ccnc1CNCc1nccn1C.c1cc(CNCc2ccncn2)ncn1.c1ccc(COCc2ccccn2)nc1.c1ccc(CSCc2ccccn2)nc1.c1cnc(CNCc2cnccn2)cn1.c1coc(CNCc2ncco2)n1.c1csc(CNCc2nccs2)n1.c1nc(CNCc2cscn2)cs1.c1ncnc(CNCc2ncncn2)n1
• InChI: InChI=1S/C14H15N3O.C13H21N5.C12H19N5.C12H12N2O.C12H12N2S.C10H15N5.2C10H11N5.C10H13N3.C8H9N7.C8H9N3O2.2C8H9N3S2/c1-12(18)17(10-13-6-2-4-8-15-13)11-14-7-3-5-9-16-14;1-10-6-12(3)17(14-10)8-16(5)9-18-13(4)7-11(2)15-18;1-9-5-11(3)16(14-9)7-13-8-17-12(4)6-10(2)15-17;2*1-3-7-13-11(5-1)9-15-10-12-6-2-4-8-14-12;1-14-5-3-12-9(14)7-11-8-10-13-4-6-15(10)2;1-3-14-9(5-11-1)7-13-8-10-6-12-2-4-15-10;1-3-11-7-14-9(1)5-13-6-10-2-4-12-8-15-10;1-3-9(12-5-1)7-11-8-10-4-2-6-13-10;1(7-12-3-10-4-13-7)9-2-8-14-5-11-6-15-8;1-3-12-7(10-1)5-9-6-8-11-2-4-13-8;1(7-3-12-5-10-7)9-2-8-4-13-6-11-8;1-3-12-7(10-1)5-9-6-8-11-2-4-13-8/h2-9H,10-11H2,1H3;6-7H,8-9H2,1-5H3;5-6,13H,7-8H2,1-4H3;2*1-8H,9-10H2;3-6,11H,7-8H2,1-2H3;1-6,13H,7-8H2;1-4,7-8,13H,5-6H2;1-2,5-6,11H,3-4,7-8H2;3-6,9H,1-2H2;1-4,9H,5-6H2;3-6,9H,1-2H2;1-4,9H,5-6H2
• InChIKey: MPRHNFIBIBTZSV-UHFFFAOYSA-N
• XLogP: 17.43
• TPSA: 634.11 Ų
• H-Bond Donors: 9
• H-Bond Acceptors: 59
• Rotatable Bonds: 52
• Heavy Atoms: 195
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2726.49
LogP ≤ 5	17.43
H-Bond Donors ≤ 5	9
H-Bond Acceptors ≤ 10	59

Frequently Asked Questions

What is the IUPAC name of N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine?

The IUPAC name of N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine (CID 159635423) is N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine.

What is the SMILES notation for N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine?

The canonical SMILES for N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine is C1=CN=C(CNCC2=NC=CC2)C1.CC(=O)N(Cc1ccccn1)Cc1ccccn1.Cc1cc(C)n(CN(C)Cn2nc(C)cc2C)n1.Cc1cc(C)n(CNCn2nc(C)cc2C)n1.Cn1ccnc1CNCc1nccn1C.c1cc(CNCc2ccncn2)ncn1.c1ccc(COCc2ccccn2)nc1.c1ccc(CSCc2ccccn2)nc1.c1cnc(CNCc2cnccn2)cn1.c1coc(CNCc2ncco2)n1.c1csc(CNCc2nccs2)n1.c1nc(CNCc2cscn2)cs1.c1ncnc(CNCc2ncncn2)n1.

What is the InChIKey of N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine?

The InChIKey is MPRHNFIBIBTZSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H15N3O.C13H21N5.C12H19N5.C12H12N2O.C12H12N2S.C10H15N5.2C10H11N5.C10H13N3.C8H9N7.C8H9N3O2.2C8H9N3S2/c1-12(18)17(10-13-6-2-4-8-15-13)11-14-7-3-5-9-16-14;1-10-6-12(3)17(14-10)8-16(5)9-18-13(4)7-11(2)15-18;1-9-5-11(3)16(14-9)7-13-8-17-12(4)6-10(2)15-17;2*1-3-7-13-11(5-1)9-15-10-12-6-2-4-8-14-12;1-14-5-3-12-9(14)7-11-8-10-13-4-6-15(10)2;1-3-14-9(5-11-1)7-13-8-10-6-12-2-4-15-10;1-3-11-7-14-9(1)5-13-6-10-2-4-12-8-15-10;1-3-9(12-5-1)7-11-8-10-4-2-6-13-10;1(7-12-3-10-4-13-7)9-2-8-14-5-11-6-15-8;1-3-12-7(10-1)5-9-6-8-11-2-4-13-8;1(7-3-12-5-10-7)9-2-8-4-13-6-11-8;1-3-12-7(10-1)5-9-6-8-11-2-4-13-8/h2-9H,10-11H2,1H3;6-7H,8-9H2,1-5H3;5-6,13H,7-8H2,1-4H3;2*1-8H,9-10H2;3-6,11H,7-8H2,1-2H3;1-6,13H,7-8H2;1-4,7-8,13H,5-6H2;1-2,5-6,11H,3-4,7-8H2;3-6,9H,1-2H2;1-4,9H,5-6H2;3-6,9H,1-2H2;1-4,9H,5-6H2.

What are the key properties of N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine?

N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine has a molecular weight of 2726.49 g/mol, XLogP of 17.43, 52 rotatable bonds, 9 hydrogen bond donors, and 59 hydrogen bond acceptors.

Where does this data come from?

All data for N,N-bis(pyridin-2-ylmethyl)acetamide;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]methanamine;1-(3,5-dimethylpyrazol-1-yl)-N-[(3,5-dimethylpyrazol-1-yl)methyl]-N-methylmethanamine;1-(1-methylimidazol-2-yl)-N-[(1-methylimidazol-2-yl)methyl]methanamine;1-(1,3-oxazol-2-yl)-N-(1,3-oxazol-2-ylmethyl)methanamine;1-pyrazin-2-yl-N-(pyrazin-2-ylmethyl)methanamine;2-(pyridin-2-ylmethoxymethyl)pyridine;2-(pyridin-2-ylmethylsulfanylmethyl)pyridine;1-pyrimidin-4-yl-N-(pyrimidin-4-ylmethyl)methanamine;1-(3H-pyrrol-2-yl)-N-(3H-pyrrol-2-ylmethyl)methanamine;1-(1,3-thiazol-2-yl)-N-(1,3-thiazol-2-ylmethyl)methanamine;1-(1,3-thiazol-4-yl)-N-(1,3-thiazol-4-ylmethyl)methanamine;1-(1,3,5-triazin-2-yl)-N-(1,3,5-triazin-2-ylmethyl)methanamine is sourced from PubChem (CID 159635423), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).